Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell therapy, raising the efficacy bar in many forms of the disease. But the ...

UK start-up Complement Therapeutics has raised an impressive €72 million ($79 million) in first-round financing that will be used to take a gene therapy for sight-robbing disease geographic atrophy ...

Abstract: In this paper, we propose a novel scheme termed layered orthogonal frequency division multiplexing with index modulation (L-OFDM-IM) to increase the spectral efficiency (SE) of OFDM-IM ...

Abstract: The non-negative matrix factorization (NMF) model with an additional orthogonality constraint on one of the factor matrices, called the orthogonal NMF (ONMF), has been found a promising ...